2018 in review
Digital/ Views & Analysis/ Views and analysis
2018 in review: AI on the rise in digital pharma
Richard Staines
2018 in review, AI, digital, Nokia
0 Comment
X
2018 in review: AI on the rise in digital pharma
https://pharmaphorum.com/views-analysis-digital/2018-digital-review-ai-on-the-rise-in-pharma/
Sales and Marketing/ Views & Analysis/ Views and analysis
2018 in review: Humira biosimilars arrive in Europe
X
2018 in review: Humira biosimilars arrive in Europe
https://pharmaphorum.com/views-analysis-sales-marketing/2018-review-humira-biosimilars-europe/
Oncology/ Views & Analysis/ Views and analysis
2018 in review: Merck & Co sets new standards in oncology, CAR-Ts hit EU market
X
2018 in review: Merck & Co sets new standards in oncology, CAR-Ts hit EU market
https://pharmaphorum.com/views-analysis-oncology/2018-in-review-merck-co-sets-new-standards-in-oncology-car-ts-hit-eu-market/
Market Access/ Views & Analysis/ Views and analysis
2018 in review: Governments start taking access seriously
George Underwood
2018 in review, market access, pricing
0 Comment
X
2018 in review: Governments start taking access seriously
https://pharmaphorum.com/views-analysis-market-access/2018-in-review-governments-start-taking-access-seriously/
Patients/ Views & Analysis/ Views and analysis
2018 in review: How patient centricity led to new drugs that tackle unmet need
X
2018 in review: How patient centricity led to new drugs that tackle unmet need
https://pharmaphorum.com/views-analysis-patients/2018-in-review-how-patient-centricity-led-to-new-drugs-that-tackle-unmet-need/